Drug Topics

JUNE 26, 2023

At the state level, medication treatment rates ranged from 17.7% in Kansas to 82.8% in Maine.

469

469

PhRMA

JUNE 26, 2023

Earlier this month, 62 researchers from our member companies came to Washington, DC to meet with congressional offices during our annual fly-in event. This year included a record-breaking number of meetings — 145 over the course of the day.

303

303

Drug Topics

JUNE 26, 2023

Electronic inhaler devices record objective inhalation quality data and permit assessment of patient efforts.

247

247

PharmaVoice

JUNE 26, 2023

Based on real-world data from patients in China, researchers were able to pinpoint factors that led to recurring infections — and which drug combos helped.

147

147

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JUNE 26, 2023

A new report recommended that ketamine therapy be used only in combination with psychotherapy under the supervision of a clinician.

247

247

STAT

JUNE 26, 2023

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT. The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom.

135

135

Pharmacy Times

JUNE 26, 2023

Liam Volk, MPharm, discussed the recent end of the FDA’s ban on gay and bisexual men donating blood, saying it’s a good step, although more must be done.

132

132

Drug Topics

JUNE 26, 2023

Shawn and Tammy from RPhAlly talk about burnout, trying to "overachieve", and how to avoid overworking yourself and your brain in this industry.

247

247

Pharmaceutical Technology

JUNE 26, 2023

After Intercept’s Ocaliva rejection, multiple companies are taking aim at becoming the first US-approved NASH therapy.

128

128

Drug Topics

JUNE 26, 2023

The once-daily oral medication is the first and only treatment approved by the agency for adolescents with the disease.

FDA 247

FDA 247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JUNE 26, 2023

This approval makes ritlecitinib, in the 50 mg dosage, the first and only treatment approved by the FDA for adolescents aged 12 years and older with severe alopecia areata.

FDA 123

FDA Dosage 123

pharmaphorum

JUNE 26, 2023

Shionogi agrees $140m deal to buy antibiotic biotech Qpex Phil.

122

122

Pharmacy Times

JUNE 26, 2023

The results of the study were presented at the 83rd Scientific Sessions of the American Diabetes Association in San Diego, California and were also published in The Lancet.

123

123

Fierce Healthcare

JUNE 26, 2023

UnitedHealth Group has once again flexed its muscles and outbid a competitor to pick up another home health asset. | Amedisys on Monday agreed to be acquired by UnitedHealth's Optum unit in an all-cash deal while also scraping a previous all-stock deal offer from previous suitor Option Care Health.

116

116

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JUNE 26, 2023

Pharmacies should start to prepare for cash flow challenges when the direct and indirect remuneration changes in 2024.

Independent Pharmacies 123

Independent Pharmacies 123

Fierce Healthcare

JUNE 26, 2023

About 2,000 registered nurses are slated to launch a one-day strike Tuesday morning and, upon completion, will be locked out of their Ascension hospitals for an additional three days, according to | The 2,000-nurse strikes are scheduled for Tuesday morning and will run a single day. However, four-day-minimum contracts for temporary staff signed by the Catholic giant to keep its hospitals active mean the union workers will be sitting out until Saturday.

Hospitals 112

Hospitals 112

Pharmacy Times

JUNE 26, 2023

This month, we have a special crossover episode between Pharmacy Focus: Oncology Edition and the Psychedelic Pharmacy podcast.

122

122

Fierce Healthcare

JUNE 26, 2023

Employers give themselves poor marks in terms of providing mental health services to their employees but high scores for supporting initiatives to improve diversity, equity and inclusion among thei | Employers recognize the importance of mental health benefits but feel that they might be falling short in providing them, according to a new survey.

112

112

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JUNE 26, 2023

Employees who did frequently use AI systems were more than likely to offer help to fellow employees, though it could have been a response to their loneliness.

122

122

pharmaphorum

JUNE 26, 2023

FDA sets out its thinking on psychedelic drug trials Phil.

FDA 105

FDA 105

Pharmacy Times

JUNE 26, 2023

Common assumptions about each generation are often incorrect, according to an expert in generational research.

Independent Pharmacies 119

Independent Pharmacies 119

pharmaphorum

JUNE 26, 2023

DexCare raises $75m for digital patient booking system Phil.

105

105

Drug Store News

JUNE 26, 2023

RK Pharma said the acquisition will give the company an exciting product portfolio, meaningful partnerships and a proven team with an impressive track record.

103

103

STAT

JUNE 26, 2023

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments. Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, a

100

100

PharmExec

JUNE 26, 2023

Drug expected to support children aged 4 and 5 with Duchenne muscular dystrophy.

FDA 98

FDA 98

STAT

JUNE 26, 2023

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence. Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year.

99

99

Drug Store News

JUNE 26, 2023

Michael Ganio, senior director of pharmacy practice and quality at The American Society of Health-System Pharmacists, highlights current shortages of medications in certain therapeutic categories.

98

98

STAT

JUNE 26, 2023

SAN DIEGO — Ozempic and Wegovy became weight loss sensations by targeting a single hormone, leading people to lose as much as 15% of their weight. But that wasn’t enough — soon there was Mounjaro , which targets two hormones, leading to 21% weight loss. Now, Eli Lilly has new results showing that an experimental drug that targets three hormones led to 24.2% weight loss in a mid-stage trial, the greatest amount seen yet with an obesity drug.

98

98

pharmaphorum

JUNE 26, 2023

Novo Nordisk, Lilly highlight oral obesity drugs at ADA Phil.

98

98

STAT

JUNE 26, 2023

“W e all know that we are in the middle of an epidemic with our youth throwers,” an orthopedic specialist opined in a March editorial. The sports medicine professionals and readers of the journal Arthroscopy may know this, but it is far from common knowledge among parents and coaches in youth baseball leagues. As scientists and sports fans, we are particularly interested in a scientific, evidence-based approach to injury prevention and sports medicine.

98

98

Drug Store News

JUNE 26, 2023

Upon completion of Kroger’s merger with Albertsons, the combined company expects to donate 10 billion meals by 2030 to feed people struggling with hunger.

98

98

STAT

JUNE 26, 2023

Biogen shareholders voted to add biotech executive Susan Langer, who is the romantic partner of departing director Alex Denner, to its board of directors on Monday, concluding a weeklong episode that led some investors to question the company’s leadership. Langer, 32, will join the eight-member board for a one-year term. Denner, who nominated her, did not stand for reelection.

98

98

European Pharmaceutical Review

JUNE 26, 2023

US Food and Drug Administration (FDA) has published its first draft guidance presenting considerations to the pharmaceutical industry for designing clinical trials for psychedelic drugs. The draft guidance is intended to advise researchers on aspects such as clinical study design as they develop medications that contain psychedelics. Dr Tiffany Farchione, Director of the Division of Psychiatry in the FDA’s Center for Drug Evaluation and Research stated the regulatory body “hopes to outline the c

FDA 98

FDA Controlled Substances 98